Trasplante combinado hepato-renal: a propósito de un caso

End stage renal disease is not an absolute contraindication for liver transplantation (LT) in patients with end stage liver disease. Actuarial patient and graft survival are comparable for children and adults who undergo LT alone and liver-kidney transplantation (LKT). The most common indications for LKT are the primary hyperoxaluria type I (PH1) and the liver and renal polycystic disease. We report a 12 years old boy with congenital hepatic fibrosis with severe portal hypertension, encephalopathy and polycystic kidney disease with end stage renal disease on dialysis that underwent LKT. During the second postoperative week, he had a biopsy-proven acute liver and renal rejection, that had a good response to corticosteroids. Thirty days after surgery, the liver biopsy was without rejection. No other complications were observed (Rev Méd Chile 2003; 131: 1309-12)

Saved in:
Bibliographic Details
Main Authors: Roque E,Jorge, Ríos M,Gloria, Hepp K,Juan, Innocenti C,Franco, Humeres A,Roberto, Palacios J,José M, Ríos R,Horacio, Suárez P,Leopoldo, Contreras M,María Angélica, Rius A,Montserrat
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2003
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003001100013
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:End stage renal disease is not an absolute contraindication for liver transplantation (LT) in patients with end stage liver disease. Actuarial patient and graft survival are comparable for children and adults who undergo LT alone and liver-kidney transplantation (LKT). The most common indications for LKT are the primary hyperoxaluria type I (PH1) and the liver and renal polycystic disease. We report a 12 years old boy with congenital hepatic fibrosis with severe portal hypertension, encephalopathy and polycystic kidney disease with end stage renal disease on dialysis that underwent LKT. During the second postoperative week, he had a biopsy-proven acute liver and renal rejection, that had a good response to corticosteroids. Thirty days after surgery, the liver biopsy was without rejection. No other complications were observed (Rev Méd Chile 2003; 131: 1309-12)